Kepivance - 66658-112-06 - (palifermin)

Alphabetical Index


Drug Information of Kepivance

Product NDC: 66658-112
Proprietary Name: Kepivance
Non Proprietary Name: palifermin
Active Ingredient(s): 6.25    mg/1.2mL & nbsp;   palifermin
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Kepivance

Product NDC: 66658-112
Labeler Name: Swedish Orphan Biovitrum AB (publ)
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125103
Marketing Category: BLA
Start Marketing Date: 20091215

Package Information of Kepivance

Package NDC: 66658-112-06
Package Description: 6 VIAL, SINGLE-USE in 1 CARTON (66658-112-06) > 1.2 mL in 1 VIAL, SINGLE-USE (66658-112-01)

NDC Information of Kepivance

NDC Code 66658-112-06
Proprietary Name Kepivance
Package Description 6 VIAL, SINGLE-USE in 1 CARTON (66658-112-06) > 1.2 mL in 1 VIAL, SINGLE-USE (66658-112-01)
Product NDC 66658-112
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name palifermin
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20091215
Marketing Category Name BLA
Labeler Name Swedish Orphan Biovitrum AB (publ)
Substance Name PALIFERMIN
Strength Number 6.25
Strength Unit mg/1.2mL
Pharmaceutical Classes Fibroblast Growth Factor 7 [Chemical/Ingredient],Increased Epithelial Proliferation [PE],Mucocutaneous Epithelial Cell Growth Factor [EPC]

Complete Information of Kepivance


General Information